Long-acting amylin analogue for weight reduction

Affiliations

¹ Pennington Biomedical Research Centre, Baton Rouge, LA, 70808, USA. Electronic address: kishore.gadde@pbrc.edu.
² Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.

Comment

Kishore M Gadde et al. Lancet. 2021.

. 2021 Dec 11;398(10317):2132-2134.

doi: 10.1016/S0140-6736(21)01999-1. Epub 2021 Nov 16.

¹ Pennington Biomedical Research Centre, Baton Rouge, LA, 70808, USA. Electronic address: kishore.gadde@pbrc.edu.
² Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.

No abstract available

Comment on

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, Pedersen SD, Pietiläinen KH, Rubino D, Batterham RL. Lau DCW, et al. Lancet. 2021 Dec 11;398(10317):2160-2172. doi: 10.1016/S0140-6736(21)01751-7. Epub 2021 Nov 16. Lancet. 2021. PMID: 34798060 Clinical Trial.